These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Baker DE; Kane S Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719 [TBL] [Abstract][Full Text] [Related]
26. [Current orientation in medical management of ulcerative colitis]. Grassi M; Raffa S; Damiani VC; Fontana M Clin Ter; 1995 May; 146(5):327-41. PubMed ID: 7796565 [TBL] [Abstract][Full Text] [Related]
29. Topical salicylate therapy (4-ASA and 5-ASA enemas). Ginsberg AL Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990 [TBL] [Abstract][Full Text] [Related]
30. 5-Aminosalicylic acid in the treatment of inflammatory bowel disease. Bondesen S; Rasmussen SN; Rask-Madsen J; Nielsen OH; Lauritsen K; Binder V; Hansen SH; Hvidberg EF Acta Med Scand; 1987; 221(3):227-42. PubMed ID: 3296672 [No Abstract] [Full Text] [Related]
31. Mechanism of action of 5-aminosalicylic acid and its derivatives. Ireland A; Jewell DP Clin Sci (Lond); 1990 Feb; 78(2):119-25. PubMed ID: 2155736 [TBL] [Abstract][Full Text] [Related]
32. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis. Abdullah AM; Scott RB; Martin SR J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):441-4. PubMed ID: 8145103 [No Abstract] [Full Text] [Related]